SCHEMBL19486019

SCHEMBL19486019

COc1ccc(NC(=O)[C@H](CCCCN)NC(=O)c2cc(NC(=O)[C@@H](N)CCCCN)ccc2OC)cc1C(=O)N[C@@H](CCCCN)C(=O)Nc1ccc(OC)c(C(=O)N[C@@H](CCCCCN)C(=O)Nc2ccc(OC)c(C(=O)N[C@H](C(=O)O)C(C)C)c2)c1

nearest known ligand 0.46

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ ERAP2 Q6P179 11/20 0.46
▸ LNPEP Q9UIQ6 10/20 0.45
▸ ERAP1 Q9NZ08 5/20 0.42
▸ SUV39H2 Q9H5I1 2/20 0.41
▸ LTA4H P09960 1/20 0.41
▸ MMP2 P08253 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19944935 1.00 ERAP2 (0.46) ERAP2LNPEPERAP1SUV39H2LTA4H
SCHEMBL21371612 1.00 ERAP2 (0.46) ERAP2LNPEPERAP1SUV39H2LTA4H
SCHEMBL19219832 0.99 ERAP2 (0.47) ERAP2LNPEPERAP1SUV39H2LTA4H
SCHEMBL10261726 0.99 ERAP2 (0.47) ERAP2LNPEPERAP1SUV39H2LTA4H
SCHEMBL19485952 0.91 ERAP2 (0.46) ERAP2LNPEPERAP1SUV39H2LTA4H
SCHEMBL21371981 0.91 ERAP2 (0.46) ERAP2LNPEPERAP1SUV39H2LTA4H
SCHEMBL12444385 0.90 ERAP2 (0.47) ERAP2LNPEPERAP1SUV39H2LTA4H
SCHEMBL19445642 0.90 ERAP2 (0.47) ERAP2LNPEPERAP1SUV39H2LTA4H
SCHEMBL10261730 0.90 ERAP2 (0.47) ERAP2LNPEPERAP1SUV39H2LTA4H
SCHEMBL10262052 0.89 ERAP2 (0.47) ERAP2LNPEPERAP1SUV39H2LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9795575-B2 Compounds for use in treatment of mucositis INNOVATION PHARMACEUTICALS INC. (US) 2017-10-24 — — US disclosed
Send feedback